Skip to main content

Eupraxia Pharmaceuticals Inc(EPRX-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Eupraxia Pharmaceuticals Inc down on Thursday (EPRX)

Automated Summaries - The Globe and Mail - Thu Apr 25, 4:02PM CDT

In today's trading, Eupraxia Pharmaceuticals Inc shares opened at $3.92 and closed at $3.90. It traded at a low of $3.89 to a high of $3.92.

Share prices dipped -0.76 percent from the previous day's close of $3.93.

Today across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 6,000 on 24 total trades, with an average volume of 30,073 in the last five days.

The TSX market on the whole today saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have shrunken -36.07%, while this year, they have dipped -27.37%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $140.00 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe